Resistance mutations of NS3 and NS5b in treatment-naïve patients infected with hepatitis C virus in Santa Catarina and Rio Grande do Sul states, Brazil
Abstract Hepatitis C virus (HCV) infection is a worldwide health problem. Nowadays, direct-acting antiviral agents (DAAs) are the main treatment for HCV; however, the high level of virus variability leads to the development of resistance-associated variants (RAVs). Thus, assessing RAVs in infected patients is important for monitoring treatment efficacy. The aim of our study was to investigate the presence of naturally occurring resistance mutations in HCV NS3 and NS5 regions in treatment-naïve patients. Ninety-six anti-HCV positive serum samples from blood donors at the Center of Hematology and Hemotherapy of Santa Catarina State (HEMOSC) were collected retrospectively in 2013 and evaluated in this study. HCV 1a (37.9%), 1b (25.3%), and 3a (36.8%) subtypes were found. The frequency of patients with RAVs in our study was 6.9%. The HCV NS5b sequencing reveled 1 sample with L320F mutation and 4 samples with the C316N/R polymorphism. The analysis of the NS3 region revealed the D168A/G/T (3.45%), S122G (1.15%), and V55A (2.3%) mutations. All samples from genotype 3a (36.8%) presented the V170 I/V non-synonymous mutation. In conclusion, we have shown that mutations in NS3 and NS5b genes are present in Brazilian isolates from therapy-naïve HCV patients.
Main Authors: | Andrade,Elisabete, Rocha,Daniele, Fontana-Maurell,Marcela, Costa,Elaine, Ribeiro,Marisa, Godoy,Daniela Tupy de, Ferreira,Antonio G.P., Tanuri,Amilcar, Brindeiro,Rodrigo, Alvarez,Patrícia |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Genética
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572020000100107 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
- CIRCULAR NS
-
Variability and resistance mutations in the hepatitis C virus NS3 protease in patients not treated with protease inhibitors
by: Zeminian,Luciana Bonome, et al.
Published: (2013) -
One-step real-time PCR assay for detection and quantification of RNA HCV to monitor patients under treatment in Brazil
by: Andrade,Elisabete, et al.
Published: (2018) - TECHNICAL BULLETIN N.S.
-
Novel NS2B/NS3-protease dengue virus inhibitors
by: Cabarcas Montalvo, María, et al.
Published: (2014)